ArticleCurrent medicinal chemistry2021

Polyisoprenylated Cysteinyl Amide Inhibitors: A Novel Approach to Controlling Cancers with Hyperactive Growth Signaling.

Nazarius S Lamango et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.